cefuroxime + erythromycin

Cefuroxime + erythromycin is a combination of two antibiotics used together, most notably in the empirical treatment of community-acquired pneumonia and other serious bacterial infections. Cefuroxime is a second-generation cephalosporin (beta-lactam) antibiotic that works by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, leading to cell lysis and death. Erythromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S ribosomal subunit, thereby blocking transpeptidation/translocation steps essential for protein assembly. This combination provides broad-spectrum coverage against both typical and atypical respiratory pathogens[4][5][6][8].